Open AccessThe Value of New Chemotherapeutic Agents for Metastatic Colorectal Cancer
Author(s) -
David H. Howard
Publication year - 2010
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2010.36
Subject(s) - life expectancy , medicine , colorectal cancer , confidence interval , value of life , cancer , population , quality of life (healthcare) , discounting , intensive care medicine , demography , environmental health , finance , business , nursing , sociology , economics , microeconomics
New chemotherapeutic agents for patients diagnosed with metastatic colorectal cancer have been singled out as examples of high-cost/low-value medical care. We measure trends in life expectancy and lifetime medical costs in this patient population between January 1, 1995, and December 31, 2005.